1. Home
  2. MP vs ALGN Comparison

MP vs ALGN Comparison

Compare MP & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MP Materials Corp.

MP

MP Materials Corp.

HOLD

Current Price

$57.67

Market Cap

11.0B

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$173.43

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MP
ALGN
Founded
2017
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Industrial Specialties
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
12.0B
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
MP
ALGN
Price
$57.67
$173.43
Analyst Decision
Strong Buy
Buy
Analyst Count
13
11
Target Price
$70.92
$192.40
AVG Volume (30 Days)
4.6M
1.2M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
12.28
0.53
EPS
N/A
5.65
Revenue
$331,952,000.00
$387,126,000.00
Revenue This Year
$114.18
$5.85
Revenue Next Year
$37.87
$4.45
P/E Ratio
N/A
$31.14
Revenue Growth
147.15
23.95
52 Week Low
$18.64
$122.00
52 Week High
$100.25
$208.31

Technical Indicators

Market Signals
Indicator
MP
ALGN
Relative Strength Index (RSI) 46.39 42.11
Support Level $51.73 $170.63
Resistance Level $65.27 $174.67
Average True Range (ATR) 3.47 5.75
MACD 0.14 -2.37
Stochastic Oscillator 40.66 23.32

Price Performance

Historical Comparison
MP
ALGN

About MP MP Materials Corp.

MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America. The company is also developing a rare earth metal, alloy, and magnet manufacturing facility in Fort Worth, Texas. The company's operations are organized into two reportable segments: Materials and Magnetics.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: